≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart CD2_INSITU_EYE_EXALLC for full statistics.

Carcinoma in situ, eye

Endpoint Browser

CD2_INSITU_EYE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • not C3_EYE_ADNEXA
519923

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D09.2&
  • Hospital discharge: ICD-9 — 2340
  • Cause of death: ICD-10 — D09.2&
  • Cause of death: ICD-9 — 2340
  • Cancer registry: Topography ICD-O-3 — C69
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 2

3 out of 7 registries used, show all original rules.

7

4. Check minimum number of events

None

7

5. Include endpoints

None

7

6. Filter based on genotype QC (FinnGen only)

7

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D09

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Not enough data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 7 - 6
Unadjusted period prevalence (%) 0.00 - 0.00
Median age at first event (years) 63.39 - 64.33

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
0
19
0.00
0.74
0.0
5.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
0
15
0.00
0.48
0.0
1.7
—
1.1
—
0
15
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
0
17
0.00
0.47
0.0
2.3
—
156.6
—
0
17
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
0
10
0.00
0.23
0.0
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.23
0.0
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.23
0.0
2.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
0
9
0.00
0.23
0.0
5.1
—
1.0
—
0
9
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
0
9
0.00
0.23
0.0
1.9
—
191.4
—
0
9
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
0
6
0.00
0.00
0.0
6.5
—
1.6
—
0
6
(3020779) Urea [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.4
—
10.7
—
0
5
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012544) pH of Venous blood
0
6
0.00
0.00
0.0
6.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
0
6
0.00
0.00
0.0
6.5
—
6.4
—
0
6
(3017143) Hepatitis C virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4010399)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_EYE – Carcinoma in situ, eye

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).